WJMSCs Anti-inflammatory Therapy in Coronary Artery Disease

NCT04551456 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease

Interventions

BIOLOGICAL: Intravenous infusion human umbilical Wharton's jelly-derived mesenchymal stem Cell or placebo PBS

Sponsor

Navy General Hospital, Beijing

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]